AGO2 Monoclonal antibody
AGO2 Monoclonal Antibody for IHC, WB, ELISA
Host / Isotype
Mouse / IgG2b
Human and More (1)
WB, RIP, IP, IHC, ELISA
Cat no : 66720-1-Ig
|Positive WB detected in||HeLa cells, HEK-293 cells, MCF-7 cells, HepG2 cells, Jurkat cells|
|Positive IHC detected in||human pancreas cancer tissue, human urothelial carcinoma tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
66720-1-Ig targets AGO2 in WB, RIP, IP, IHC, ELISA applications and shows reactivity with Human samples.
|Host / Isotype||Mouse / IgG2b|
|Immunogen||AGO2 fusion protein Ag17723|
|Full Name||eukaryotic translation initiation factor 2C, 2|
|Calculated molecular weight||97 kDa|
|Observed molecular weight||97 kDa|
|GenBank accession number||BC007633|
|Gene ID (NCBI)||27161|
|Purification Method||Protein A purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
EIF2C2, also named as AGO2, belongs to the argonaute family and Ago subfamily. It is required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include EIF2C2/AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). EIF2C2 may inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. It also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. EIF2C2 can also upregulate the translation of specific mRNAs under certain growth conditions.
|Product Specific Protocols|
|WB protocol for AGO2 antibody 66720-1-Ig||Download protocol|
|IHC protocol for AGO2 antibody 66720-1-Ig||Download protocol|
|Click here to view our Standard Protocols|
Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression.
CircZNF208 enhances the sensitivity to X-rays instead of carbon-ions through the miR-7-5p /SNCA signal axis in non-small-cell lung cancer cells.
LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
J Bone Miner Metab
Regulation of circADAMTS6-miR-324-5p-PIK3R3 ceRNA pathway may be a novel mechanism of IL-1β-induced osteoarthritic chondrocytes.
J Orthop Surg Res
Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation.